237 related articles for article (PubMed ID: 28552865)
1. [New development of diagnosis and treatment for Parkinson's disease].
Orimo S
Rinsho Shinkeigaku; 2017 Jun; 57(6):259-273. PubMed ID: 28552865
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.
Fujita H; Suzuki K; Numao A; Watanabe Y; Uchiyama T; Miyamoto T; Miyamoto M; Hirata K
PLoS One; 2016; 11(11):e0165869. PubMed ID: 27812167
[TBL] [Abstract][Full Text] [Related]
3. MIBG myocardial scintigraphy in pre-motor Parkinson's disease: a review.
Sakakibara R; Tateno F; Kishi M; Tsuyusaki Y; Terada H; Inaoka T
Parkinsonism Relat Disord; 2014 Mar; 20(3):267-73. PubMed ID: 24332912
[TBL] [Abstract][Full Text] [Related]
4. [Initial diagnosis of Parkinson's disease - neuroradiological diagnosis].
Orimo S
Rinsho Shinkeigaku; 2013; 53(11):977-80. PubMed ID: 24291851
[TBL] [Abstract][Full Text] [Related]
5. Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.
Stiasny-Kolster K; Doerr Y; Möller JC; Höffken H; Behr TM; Oertel WH; Mayer G
Brain; 2005 Jan; 128(Pt 1):126-37. PubMed ID: 15548552
[TBL] [Abstract][Full Text] [Related]
6. Relationship between (123)I-MIBG scintigrams and REM sleep behavior disorder in Parkinson's disease.
Nomura T; Inoue Y; Högl B; Uemura Y; Kitayama M; Abe T; Miyoshi H; Nakashima K
Parkinsonism Relat Disord; 2010 Dec; 16(10):683-5. PubMed ID: 20846893
[TBL] [Abstract][Full Text] [Related]
7. Combination of transcranial sonography, olfactory testing, and MIBG myocardial scintigraphy as a diagnostic indicator for Parkinson's disease.
Izawa MO; Miwa H; Kajimoto Y; Kondo T
Eur J Neurol; 2012 Mar; 19(3):411-6. PubMed ID: 21978091
[TBL] [Abstract][Full Text] [Related]
8. Prodromal Parkinson's Disease: The Decade Past, the Decade to Come.
Postuma RB; Berg D
Mov Disord; 2019 May; 34(5):665-675. PubMed ID: 30919499
[TBL] [Abstract][Full Text] [Related]
9. Transcranial sonography in relation to SPECT and MIBG.
Kajimoto Y; Miwa H; Kondo T
Int Rev Neurobiol; 2010; 90():48-62. PubMed ID: 20692493
[TBL] [Abstract][Full Text] [Related]
10. Combined use of dopamine transporter imaging (DAT-SPECT) and
Yoshii F; Ryo M; Baba Y; Koide T; Hashimoto J
J Neurol Sci; 2017 Apr; 375():80-85. PubMed ID: 28320195
[TBL] [Abstract][Full Text] [Related]
11. Transcranial sonography of the substantia nigra and MIBG myocardial scintigraphy: complementary role in the diagnosis of Parkinson's disease.
Kajimoto Y; Miwa H; Okawa-Izawa M; Hironishi M; Kondo T
Parkinsonism Relat Disord; 2009 May; 15(4):270-2. PubMed ID: 18691928
[TBL] [Abstract][Full Text] [Related]
12. Orthostatic hypotension and cardiac sympathetic denervation in Parkinson disease patients with REM sleep behavioral disorder.
Kim JS; Park HE; Oh YS; Lee SH; Park JW; Son BC; Lee KS
J Neurol Sci; 2016 Mar; 362():59-63. PubMed ID: 26944118
[TBL] [Abstract][Full Text] [Related]
13. Importance of (123)I-ioflupane SPECT and Myocardial MIBG Scintigraphy to Determine the Candidate of Deep Brain Stimulation for Parkinson's Disease.
Asahi T; Kashiwazaki D; Yoneyama T; Noguchi K; Kuroda S
Neurol Med Chir (Tokyo); 2016; 56(3):125-31. PubMed ID: 26794041
[TBL] [Abstract][Full Text] [Related]
14. The combined effect of REM sleep behavior disorder and hyposmia on cognition and motor phenotype in Parkinson's disease.
Kang SH; Lee HM; Seo WK; Kim JH; Koh SB
J Neurol Sci; 2016 Sep; 368():374-8. PubMed ID: 27538667
[TBL] [Abstract][Full Text] [Related]
15. Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder.
Iranzo A; Stockner H; Serradell M; Seppi K; Valldeoriola F; Frauscher B; Molinuevo JL; Vilaseca I; Mitterling T; Gaig C; Vilas D; Santamaria J; Högl B; Tolosa E; Poewe W
Mov Disord; 2014 Dec; 29(14):1774-80. PubMed ID: 25384461
[TBL] [Abstract][Full Text] [Related]
16. Nigro-caudate dopaminergic deafferentation: a marker of REM sleep behavior disorder?
Arnaldi D; De Carli F; Picco A; Ferrara M; Accardo J; Bossert I; Famà F; Girtler N; Morbelli S; Sambuceti G; Nobili F
Neurobiol Aging; 2015 Dec; 36(12):3300-3305. PubMed ID: 26410306
[TBL] [Abstract][Full Text] [Related]
17. Cardiac ¹²³I-MIBG scintigraphy as an outcome-predicting tool for subthalamic nucleus stimulation in Parkinson's disease.
Yamada K; Shiraishi SY; Hamasaki T; Kuratsu J
Acta Neurochir (Wien); 2010 Dec; 152(12):2063-8. PubMed ID: 20927559
[TBL] [Abstract][Full Text] [Related]
18. Beating a dead horse: dopamine and Parkinson disease.
Ahlskog JE
Neurology; 2007 Oct; 69(17):1701-11. PubMed ID: 17954785
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic imaging in Parkinson's disease.
Orimo S
Nihon Rinsho; 2017 Jan; 75(1):48-55. PubMed ID: 30566294
[TBL] [Abstract][Full Text] [Related]
20. EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease.
Berardelli A; Wenning GK; Antonini A; Berg D; Bloem BR; Bonifati V; Brooks D; Burn DJ; Colosimo C; Fanciulli A; Ferreira J; Gasser T; Grandas F; Kanovsky P; Kostic V; Kulisevsky J; Oertel W; Poewe W; Reese JP; Relja M; Ruzicka E; Schrag A; Seppi K; Taba P; Vidailhet M
Eur J Neurol; 2013 Jan; 20(1):16-34. PubMed ID: 23279440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
